These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14979258)

  • 41. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
    Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
    Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AIDS vaccine fails in Thai trial.
    McCarthy M
    Lancet; 2003 Nov; 362(9397):1728. PubMed ID: 14655660
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First AIDS vaccine tested did not protect, but gives scientific leads.
    James JS
    AIDS Treat News; 2003 Mar; (389):6. PubMed ID: 12712937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines.
    AIDS Policy Law; 1999 Aug; 14(14):12. PubMed ID: 11367001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of full-length glycoprotein 120 from incident HIV type 1 subtype E and B infections in Bangkok injecting drug users with prototype E and B strains that are components of a candidate vaccine.
    Phan KO; Callahan ME; Vanichseni S; Hu DJ; Raktham S; Young N; Choopanya K; Mastro TD; Subbarao S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1445-50. PubMed ID: 11018864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine news from the 12th World AIDS Conference.
    Mirken B
    BETA; 1998 Oct; ():26-9. PubMed ID: 11365985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
    Francis DP; Gregory T; McElrath MJ; Belshe RB; Gorse GJ; Migasena S; Kitayaporn D; Pitisuttitham P; Matthews T; Schwartz DH; Berman PW
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S325-31. PubMed ID: 9814961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. gp 120: good, bad or indifferent?
    Steele FR
    Nat Med; 1995 Nov; 1(11):1105-6. PubMed ID: 7584971
    [No Abstract]   [Full Text] [Related]  

  • 51. Jury still out on HIV vaccine results.
    Butler D
    Nature; 2009 Oct; 461(7268):1187. PubMed ID: 19865138
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ethical elements in the development of vaccines against HIV/AIDS].
    Molina CN
    Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV-vaccine research and development in Thailand: evolution and challenges.
    Pitisuttithum P; Choopanya K; Rerk-Ngnam S
    Vaccine; 2010 May; 28 Suppl 2():B45-9. PubMed ID: 20510743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outstanding questions on HIV vaccine trial.
    Jefferys R; Harrington M
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
    [No Abstract]   [Full Text] [Related]  

  • 55. Skeptical scientists skewer VaxGen statistics.
    Watanabe ME
    Nat Med; 2003 Apr; 9(4):376. PubMed ID: 12669042
    [No Abstract]   [Full Text] [Related]  

  • 56. AIDS research. Debate begins over new vaccine trials.
    Cohen J
    Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
    [No Abstract]   [Full Text] [Related]  

  • 57. Support for the RV144 HIV vaccine trial.
    AIDS Vaccine Advocacy Coalition
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
    [No Abstract]   [Full Text] [Related]  

  • 58. An HIV vaccine--evolving concepts.
    Johnston MI; Fauci AS
    N Engl J Med; 2007 May; 356(20):2073-81. PubMed ID: 17507706
    [No Abstract]   [Full Text] [Related]  

  • 59. Support for the RV144 HIV vaccine trial.
    Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract]   [Full Text] [Related]  

  • 60. Thailand's Prime-Boost HIV Vaccine Phase III.
    Trinvuthipong C
    Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.